Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Can+Commun+Dis+Rep 2014 ; 40 (18): 385-7 Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Developing a cells, tissue and organ surveillance system #MMPMID29769869
Hong Z; Kenny P; Hyson C; Archibald C
Can Commun Dis Rep 2014[Nov]; 40 (18): 385-7 PMID29769869show ga
Background: An increasing number of cell, tissue and organ transplant procedures take place each year in Canada, including procedures in clinics, physician and dental offices. The Public Health Agency of Canada (the Agency) is leading the development of a Cell, Tissue and Organ Surveillance System (CTOSS). Objective: To create timely, useful and relevant national-level transplantation adverse event data by supporting the development and / or enhancement of provincial and territorial data collection systems. Methods: Minimum data elements and definitions were established for tissues based on definitions established in the European Union and the United States. Data collection on adverse events related to human allograft tissue transplants began in April 2011 at pilot sites in Alberta, Ontario, Quebec, New Brunswick and Nova Scotia. Results: By December 2013, eight tissue transplantation adverse events were reported. Seven involved corneal tissue and one involved cardiovascular tissue. Conclusion: A fully developed CTOSS could increase Canadian capacity to improve patient safety. Data collection and analysis could increase the potential for a better understanding of transplantation adverse events, subsequently inform the development of strategies for overall prevention and reduce the severity of such events. The next steps in developing CTOSS will be to establish data elements and definitions for the cell and organ transplant components of the system and increase the number of pilot sites.
free
free
free
Can+Commun+Dis+Rep 2014 ; 40 (18): 385-7
